Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

Clinical trial NCT04156685 · COMPLETED

Trial details

NCT number: NCT04156685
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2019-08-06
Primary completion: 2019-08-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.